Clinical Trial Update: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV) [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study of Sapablursen evaluating safety and efficacy in participants with Polycythemia vera, which is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Sapablursen (sapablursen)

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Polycythemia Vera | Phase 3 | Status: NOT_YET_RECRUITING